ADGRL4 and neoplasm: Tissue microarrays representing tumor cores from 99 patients diagnosed with mRCC that had undergone nephrectomy and were treated with sunitinib in first or second line therapy were stained using ELTD1-specific antibodies as described in materials and methods.